Please assess the completion status of the following clinical trial:

Trial Title: C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Key Inclusion Criteria:~* Documented congenital C1-INH deficiency~* Acute HAE attack~* Participation in base study CE1145_3001 (NCT00168103)~Key Exclusion Criteria:~* Acquired angioedema~* Treatment with any other investigational drug besides CE1145 in the last 30 days before study entry

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- C1 Esterase Inhibitor (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).